Skip to content
POM-V Prescription Required Companion Animal

Leucofeligen FeLV/RCP Lyophilisate and Solvent for Suspension for Injection for Cats

Active ingredients: Feline calicivirus, Feline leukemia virus, Feline panleukopenia virus, Feline viral rhinotracheitis virus

Form

Injection

Species

Cats

Manufacturer

Virbac

VMD MA No.

05653/5013

What it's used for

Active immunisation of cats aged 8 weeks and older: - - Onset of immunity: 1 week after primary vaccination course. Duration of immunity: 1 year after prim...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Feline calicivirus + Feline...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Leucofeligen FeLV/RCP Lyophilisate and Solvent for Suspension for Injection for Cats — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Active immunisation of cats aged 8 weeks and older:
-
-
Onset of immunity: 1 week after primary vaccination course.
Duration of immunity: 1 year after primary vaccination course and 3 years after the
last re-vaccination.
None.
Cats:
Common
(1 to 10 animals / 100 animals
treated):
Apathy, anorexia, and hyperthermia
Injection site reactions (pain, itching,
oedema)
.
Uncommon
(1 to 10 animals / 1,000 animals
treated):
Hypersensitivity reaction
Very rare
(<1 animal / 10,000 animals treated,
including isolated reports):
Emesis
1 lasting usually for 1 or 2 days.
2 slight pain at palpation, itching or limited oedema disappearing within 1 or 2 weeks
at most.
3 may require appropriate symptomatic treatment.
4 mostly within 24 to 48 hours.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See section “Contact details”
of the package leaflet.
Vaccinate healthy animals only.

Revised: July 2023
AN: 02300/2022Page 2 of 5

Special precautions for use in animals
None.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
Safety and efficacy data are available which demonstrate that this vaccine can be
mixed and administered with Boehringer Ingelheim non-adjuvanted vaccine against
feline leukaemia and/or administered the same day but not mixed with Boehringer
Ingelheim adjuvanted vaccine against rabies.
Safety and efficacy data are available which demonstrate that this vaccine can be
mixed and administered with Boehringer Ingelheim non-adjuvanted vaccine against
rabies.

Revised: July 2023
AN: 02300/2022Page 3 of 5
No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product except the products mentioned above. A
decision to use this vaccine before or after any other veterinary medicinal product
therefore needs to be made on a case-by-case basis.
Store and transport refrigerated (2
o
C – 8
o
C).
Protect from light.
Do not freeze.
Not applicable.
5. IMMUNOLOGICAL PROPERTIES
ATCvet Code: QI06AH08. Live feline rhinotracheitis virus + inactivated feline
calicivirus antigen.
Vaccine against feline viral rhinotracheitis and feline calicivirosis.
Stimulates active immunity against feline rhinotracheitis herpesvirus and feline
calicivirus.

Revised: July 2023
AN: 02300/2022Page 4 of 5
The veterinary medicinal product was shown to reduce excretion of feline calicivirus
at onset of immunity and for one year after vaccination.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.